Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular endothelial growth factor (VEGF) secretion refers to the process by which cells release VEGF, a heparin-binding glycoprotein that plays a central role in angiogenesis (the formation of new blood vessels), vasculogenesis, and vascular permeability. VEGF secretion is tightly regulated by factors such as hypoxia, cytokines, growth factors, oncogenes, and tumor suppressors, and its dysregulation is implicated in various diseases, particularly cancer.
VEGF secretion itself is not a mechanism of action but rather a process. Drugs target the VEGF molecule or its receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Endothelial Growth Factor Secretion (None).